ArticleArchives of dermatological research2025
Dysplastic nevi and malignant melanoma: insights into pre-biopsy diagnostic accuracy and the critical role of dermatology consultation.
Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- In vivo molecular skin fluorescence imaging for noninvasive assessment of atypical nevi and melanoma: A validation trial.JAAD international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A dysplastic nevus (DN) is an acquired melanocytic nevus that displays clinical and histological features similar to malign melanoma (MM). This study aims to evaluate the demographic and clinical characteristics of DN and primary cutaneous MM, as well as assess the accuracy of pre-biopsy diagnoses. We retrospectively analyzed 206 histopathologically confirmed cases of DN (n = 185) and MM (n = 21) from 159 patients at a tertiary care center. The biopsy samples had been sent from both dermatology and other surgical departments. The study included 21 patients with MM and 139 with DN; one patient had both conditions. The mean age was 60.6 ± 15.9 years for MM patients and 34.7 ± 14.9 years for DN patients, both with a slight male predominance. Melanomas were predominantly on the face (42.9%), whereas DN lesions were mostly on the trunk (76.8%). Breslow thickness analysis showed 33.3% of MM tumors were < 1 mm and 28.6% were > 4 mm. In 90.5% of MM cases and 71.4% of DN cases, preliminary diagnoses of MM and/or DN were noted on pathology request forms. Overall, pre-biopsy diagnoses were consistent with final diagnoses in 73.3% of the 206 lesions. Diagnostic accuracy was higher in dermatology compared to other surgical departments (85.8% vs. 50%, p <.00001) and was better for trunk and feet locations compared to unspecified areas (p = .023 and p = .044, respectively). The study highlights the need for dermatology consultation before excising nevi or suspicious lesions and emphasizes early melanoma detection. Despite the small sample size, it underscores the importance of enhanced screening methods and awareness campaigns.
Indexed as
Identifiers
40095074What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.